Artal Group S.A. — Q4 2025 13F-HR

← Artal Group S.A.

Q4 2025 · 13F-HR

Artal Group S.A.holdings as filed

Filed 2026-02-12 · accession 0001053906-26-000003

$714.6M

Reported value

Positions

2025-12-31

Period end

View analyzed profile →PRO

The Brief · Artal Group S.A. · Q4 2025

AI · grounded in 13F

Artal Group S.A. reported no changes to its 13F holdings for 2025-12-31 relative to 2025-09-30.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
148929102	CAVA	Cava Group Inc	$558.0M	78.1%	9,507,990	Common	SOLE
528872302	LXRX	Lexicon Pharmaceuticals Inc	$156.6M	21.9%	136,180,481	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.